Artemis Therapeutics, Inc. (CIK: 0001062128) EDGAR, Information, Filings... CompaniesBIO.Com

Artemis Therapeutics, Inc.

Mailing address
18 EAST 16TH STREET, NEW YORK, Delaware, 10003
Phone
646-233-1454
State location
New York
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2890 - (CF Office: Office of Life Sciences) MISCELLANEOUS CHEMICAL PRODUCTS
Filings
N/A

Artemis Therapeutics, Inc. (CIK: 0001062128) is an American company incorporated in the state of New York. Head office is located at 18 EAST 16TH STREET, NEW YORK, New York, 10003. Work in the industry 2890 - (CF Office: Office of Life Sciences) MISCELLANEOUS CHEMICAL PRODUCTS. Artemis Therapeutics, Inc. is a public company and trade via Over-The-Counter (OTC).

Old names:

NEW YORK GLOBAL INNOVATIONS INC. from 2013-18-Nov to 2016-15-Dec
INKSURE TECHNOLOGIES INC. from 2005-14-Apr to 2014-14-Feb
INKSURE TECHNOLOGIES INC from 2003-08-Jan to 2005-30-Mar
LIL MARC INC from 1998-14-Aug to 2002-25-Nov

Owner	Filings	Transaction Date	Type of Owner
Dana David	0001941972	Jul-26-2022	officer: Chief Financial Officer
CITRON SHIMON	0001284150	Jun-30-2022	director, officer: Chief Executive Officer
Culley Brian M	0001310683	Aug-09-2017	officer: Chief Executive Officer
PAYNE PETER N.	0001694953	Jan-10-2017	officer: Chief Executive Officer
Wolf Dana	0001683954	Aug-23-2016	officer: Chief Scientific Officer
Tonak Ltd.	0001684314	Aug-23-2016	10 percent owner
Alfassi Israel	0001684401	Aug-23-2016	director
Morris Chanan	0001621439	Oct-10-2014	officer: Chief Financial Officer
Arias Roberto Alonso Jimenez	0001602111	Feb-11-2014	director
Assis Tomer	0001595208	Dec-13-2013	officer: Chief Financial Officer
SASS DAVID W	0001218852	Mar-02-2011	director, officer: Secretary
Avner David	0001502368	Sep-21-2010	officer: CHIEF FINANCIAL OFFICER
Bettsak Jonathan	0001496503	May-27-2010	director
Gilat Tal	0001486316	Mar-02-2010	officer: President and CEO
Raich Alon	0001478641	Sep-23-2009	director
Goldovsky Viktor	0001554070	Jul-01-2009	officer: VP Sales and Buisness Dev
Peleg Gadi	0001443071	Aug-07-2008	director
PEKER TZLIL	0001433025	Apr-23-2008	officer: Vice President and CFO
SEIDMAN SAMUEL N	0001042971	Mar-28-2007	director
Rock Randy F	0001391331	Feb-16-2007	director
ICTS INTERNATIONAL N V	0001010134	Dec-05-2006	10 percent owner
BRANDT MICKEY	0001379428	Sep-01-2006	officer: VP and CFO
Schoenheimer Pierre Lucien	0001374026	Aug-22-2006	director
L & Co., LLC	0001358824	Apr-05-2006	10 percent owner
GETTER PHILIP	0001106806	Feb-01-2006	director
ACKS MICHAEL	0001285615	Feb-01-2006	director
ATTIAS ALBERT	0001285885	Feb-01-2006	director
BIGON EYAL	0001285472	Jan-12-2006	officer: Chief Financial Officer
LINEBERGER JAMES E	0001180751	Feb-01-2005	director
MEERFELD YARON	0001205404	Feb-24-2004	director, officer: Chief Executive Officer
HOUSMAN ELIE	0001169898	Aug-01-2003	director, officer: Chairman

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Artemis Therapeutics, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001213900-23-088864 (34 Act) Size: KB	Nov-21-2023	000-24431 231423942
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001213900-23-086890 (34 Act) Size: KB	Nov-14-2023	000-24431 231405638
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001213900-23-067747 (34 Act) Size: KB	Aug-15-2023	000-24431 231174819
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001213900-23-067304 (34 Act) Size: KB	Aug-15-2023	000-24431 231172436
EFFECT	Document	Acc-no: 9999999995-23-001546 (33 Act) Size: KB	May-26-2023	333-267534 23971242
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001178913-23-002015 (33 Act) Size: KB	May-23-2023	333-267534 23945860
8-K	Document	Current report filing Acc-no: 0001178913-23-002013 (34 Act) Size: KB	May-22-2023	000-24431 23944548
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001178913-23-001959 (34 Act) Size: KB	May-18-2023	000-24431 23936137
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001178913-23-001906 (34 Act) Size: KB	May-15-2023	000-24431 23924294
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001178913-23-001856 (33 Act) Size: KB	May-12-2023	333-267534 23914475
10-K/A	Document	Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0001178913-23-001679 (34 Act) Size: KB	May-03-2023	000-24431 23884613
10-K/A	Document	Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0001178913-23-001351 (34 Act) Size: KB	Apr-06-2023	000-24431 23806641
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001178913-23-001267 (34 Act) Size: KB	Mar-31-2023	000-24431 23787129
EFFECT	Document	Acc-no: 9999999995-23-000030 (33 Act) Size: KB	Jan-04-2023	333-267534 23509636
S-1/A	Document	Amendment to General form of registration statement for all companies including face-amount certificate companies Acc-no: 0001178913-23-000043 (33 Act) Size: KB	Jan-04-2023	333-267534 23505955
CORRESP	Document	A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001178913-22-004452 ( Act) Size: KB	Dec-30-2022
CORRESP	Document	A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001178913-22-004385 ( Act) Size: KB	Dec-20-2022
S-1/A	Document	Amendment to General form of registration statement for all companies including face-amount certificate companies Acc-no: 0001178913-22-004383 (33 Act) Size: KB	Dec-20-2022	333-267534 221474052
UPLOAD	Document	Acc-no: 0000000000-22-013009 ( Act) Size: KB	Dec-02-2022
S-1/A	Document	Amendment to General form of registration statement for all companies including face-amount certificate companies Acc-no: 0001178913-22-004114 (33 Act) Size: KB	Nov-21-2022	333-267534 221405591

Recent 20 filings. View all Artemis Therapeutics, Inc. filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Artemis Therapeutics, Inc. overview
Artemis Therapeutics, Inc. job
Artemis Therapeutics, Inc. stock
Artemis Therapeutics, Inc. ownership
Artemis Therapeutics, Inc. CEO
Artemis Therapeutics, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.